Exane Derivatives’s Acuity Brands AYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$187K Buy
1,215
+124
+11% +$21K 0.11% 173
2022
Q1
$207K Sell
1,091
-161
-13% -$30.9K 0.06% 325
2021
Q4
$265K Sell
1,252
-83
-6% -$17.2K 0.06% 287
2021
Q3
$231K Buy
1,335
+228
+21% +$40K 0.06% 359
2021
Q2
$187K Buy
+1,107
New +$201K 0.04% 424
2019
Q4
Sell
-623
Closed -$84K 683
2019
Q3
$84K Hold
623
0.02% 331
2019
Q2
$85.9K Sell
623
-773
-55% -$106K 0.02% 345
2019
Q1
$167K Buy
1,396
+545
+64% +$67.8K 0.03% 236
2018
Q4
$97.8K Buy
851
+850
+85,000% +$105K 0.02% 323
2018
Q3
$158 Sell
1
-3,408
-100% -$489K ﹤0.01% 603
2018
Q2
$400K Buy
3,409
+1,917
+128% +$234K 0.07% 194
2018
Q1
$204K Buy
1,492
+1,236
+483% +$190K 0.04% 236
2017
Q4
$45K Sell
256
-53
-17% -$8.82K 0.01% 348
2017
Q3
$52.9K Buy
+309
New +$57.6K 0.01% 303

Other funds holding AYI

Exane Derivatives's AYI Position: Q2 2022 in Review

Exane Derivatives increased its Acuity Brands (AYI) stake by 11% in Q2 2022, buying an estimated $21K and bringing the position to 1,215 shares worth $187K. The position accounts for 0.11% of the portfolio, ranked #173.

Exane Derivatives first reported a position in AYI in Q3 2017 and has held it in 14 quarters since. The position peaked at $400K in Q2 2018. 354 funds tracked by Wall St. Rank hold AYI as of Q2 2022.

  • Exane Derivatives held 1,215 shares of Acuity Brands worth $187K as of Q2 2022.
  • Exane Derivatives bought 124 Acuity Brands shares in Q2 2022, an estimated $21K.
  • Acuity Brands made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #173 holding.
  • Exane Derivatives first reported a position in Acuity Brands in Q3 2017 and has held it in 14 quarters since.
  • Exane Derivatives's Acuity Brands position peaked at $400K in Q2 2018.
  • 354 funds tracked by Wall St. Rank held Acuity Brands as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.